Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Patient safety

Contaminated batches of Zovirax eye ointment recalled

Contaminated batches of Zovirax (aciclovir) eye ointment — used for the local treatment of herpes simplex infections — are being recalled after metal particles were found in an ingredient used in its manufacture.

Product shortages are already being reported because there are no alternative batches available from manufacturer GlaxoSmithKline. It will be several months before new batches are available.

In a memo accompanying the Medicines and Healthcare products Regulatory Agency recall, the UK medicines information service (UKMi) suggests a number of alternative treatments available to treat the condition.

The only other topical product licensed in the UK for herpes simplex keratitis is ganciclovir 0.15% eye gel (Virgan). Another option would be a course of oral aciclovir.

Aciclovir 3% eye ointment may be available as an imported medicine but it is unlicensed in the UK, the memo points out. Tifluorothymidine 1% drops (trifluridine, Viroptic) are another unlicensed option, it suggests.

The affected Zovirax products carry the batch numbers 3L942 and 3M941, with expiry dates of October 2018 and January 2019, respectively. They were first distributed in January and April 2014.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067063

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.